Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 258

    1.

    Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

    Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study.

    Diabetes Care. 2003 Jul;26(7):2165-73.PMID: 12832330 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

    Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

    Diabetologia. 2005 Feb;48(2):370-8. Epub 2005 Feb 4.PMID: 15692810 [PubMed - indexed for MEDLINE]Related articles

    3.

    Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.

    Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL, Chung JS, O'Neal DN, Januszewski AS, Croft KD, Mori TA, Dragicevic G, Harper CA, Best JD, Lyons TJ, Ma JX.

    Diabet Med. 2007 Dec;24(12):1345-51. Epub 2007 Oct 29.PMID: 17971181 [PubMed - indexed for MEDLINE]Related articles

    4.

    Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

    Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Dräger AM, Doni A, van Hinsbergh VW, Stehouwer CD.

    Diabetologia. 1999 Mar;42(3):351-7.PMID: 10096789 [PubMed - indexed for MEDLINE]Related articles

    5.

    Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.

    Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G; Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort Study Group.

    Diabetes Care. 2008 Oct;31(10):2006-12. Epub 2008 Jul 15.PMID: 18628568 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.

    Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.

    Circulation. 2005 May 17;111(19):2446-53. Epub 2005 May 2.PMID: 15867184 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.

    Stam F, Schalkwijk CG, van Guldener C, ter Wee PM, Stehouwer CD.

    Nephrol Dial Transplant. 2006 Mar;21(3):677-82. Epub 2005 Dec 5.PMID: 16330467 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.

    García-Unzueta MT, Berrazueta JR, Pesquera C, Obaya S, Fernández MD, Sedano C, Amado JA.

    J Diabetes Complications. 2005 May-Jun;19(3):147-54.PMID: 15866060 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

    Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS.

    Diabetes Care. 2003 Jun;26(6):1745-51.PMID: 12766104 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

    Meigs JB, Hu FB, Rifai N, Manson JE.

    JAMA. 2004 Apr 28;291(16):1978-86.PMID: 15113816 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.

    Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.

    Diabetes Care. 2008 Jun;31(6):1170-6. Epub 2008 Mar 10.PMID: 18332153 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

    Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF.

    Diabetes. 2003 Mar;52(3):812-7.PMID: 12606524 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes.

    Leinonen E, Hurt-Camejo E, Wiklund O, Hultén LM, Hiukka A, Taskinen MR.

    Atherosclerosis. 2003 Feb;166(2):387-94.PMID: 12535753 [PubMed - indexed for MEDLINE]Related articles

    17.

    Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.

    Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

    Diabetologia. 2009 Apr;52(4):705-14. Epub 2009 Jan 30.PMID: 19183936 [PubMed - indexed for MEDLINE]Related articles

    19.

    Inflammatory markers and risk of developing type 2 diabetes in women.

    Hu FB, Meigs JB, Li TY, Rifai N, Manson JE.

    Diabetes. 2004 Mar;53(3):693-700.PMID: 14988254 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.

    Smulders RA, Stehouwer CD, Schalkwijk CG, Donker AJ, van Hinsbergh VW, TeKoppele JM.

    Thromb Haemost. 1998 Jul;80(1):52-7.PMID: 9684785 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data